Compare DexCom, Inc. (DXCM) vs Quanta Services Inc (PWR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Quanta Services Inc — how do they compare? DexCom, Inc. trades at $84.14 (market cap $31.86B), while Quanta Services Inc trades at $700.31 (market cap $103.03B). The key difference: Quanta Services Inc is far larger — about 3.2× DexCom, Inc.'s market cap, and Quanta Services Inc pays a 0.06% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and Quanta Services Inc for 62 Days on average.
| DXCM | PWR | |
|---|---|---|
Market Cap | $31.86B | $103.03B |
Volume | 3,607,070 | 977,892 |
Sector | Health | Industrials |
52-Week High | $92.34 | $785.24 |
52-Week Low | $54.84 | $412.21 |
Typical Hold Time | 62 Days | 62 Days |
Enterprise Value | $31.32B | $109.13B |
Dividend Yield | — | 0.06% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $84.11, down 0.23% on the day, with a bearish technical signal but strong fundamental performance. The company reported Q2 2026 EPS of $0.70, beating expectations, and has shown consistent revenue growth, with 2025 revenue reaching $4.66 billion and net income of $836.3 million. Analyst consensus is strongly bullish with an 80.77% buy rating and a $95.07 price target. Recent news highlights growth opportunities in Type 2 diabetes care and key executive promotions.
The outlook for DXCM is positive due to robust earnings beats, expanding market opportunities, and strong institutional support. However, risks include competitive pressures, reimbursement challenges, and a high valuation with a P/E of 33.38. The stock presents a growth opportunity but requires monitoring of execution against these risks.
PWR trades at $705.94, up 0.69% today, with a bullish technical signal and strong analyst support. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue growth is robust, reaching $28.48B in 2025, though valuation multiples like a P/E of 78.41 appear elevated. Positive sentiment is driven by a record $53B backlog and AI infrastructure demand, as highlighted in recent Zacks reports.
Outlook remains positive given earnings momentum and sector tailwinds, but high valuation and execution risks from rapid expansion warrant caution. The consensus price target of $802.08 implies upside, yet investors should monitor margin sustainability and competitive pressures in the construction and electrical services sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Quanta Services Inc
Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under two reportable segments: electric power infrastructure solutions and underground utility and infrastructure solutions. In October 2021, the company completed the acquisition of Blattner, a provider of comprehensive engineering, procurement, and construction solutions to customers in the renewable energy industry.
Read more on PWR →
